Ira Baeringer has been appointed vice president of business development at Intellipharmaceutics International Inc. Mr. Baeringer will assist the commercialization of products in the company’s controlled-release generic drug Abbreviated New Drug Applications (ANDA) portfolio and 505(b)(2) New Drug Application (NDA) portfolio across markets both in and outside the U.S. Mr. Baeringer has 20 years of experience in pharmaceutical licensing, development, supply, acquisitions, divestitures, and allian...